---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/280991808.md"
description: "Sinovac Biotech: GB19 injection receives FDA Investigational New Drug approval"
datetime: "2026-03-30T09:40:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/280991808.md)
  - [en](https://longbridge.com/en/news/280991808.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/280991808.md)
---

# 

Sinovac Biotech: GB19 injection receives FDA Investigational New Drug approval.

### Related Stocks

- [688136.CN](https://longbridge.com/en/quote/688136.CN.md)

## Related News & Research

- [20:17 ETÜber den Horizont hinaus, gemeinsam immer weiter | Kexing Biopharm zieht Bilanz für seine Teilnahme an der CPHI & PMEC China 2026](https://longbridge.com/en/news/290752726.md)
- [23:39 ETBeyond Horizons, Forward Together | Kexing Biopharm Concludes Participation in CPHI & PMEC China 2026](https://longbridge.com/en/news/290639584.md)
- [08:05 ETAccord Healthcare Launches Sugammadex Injection, Expanding Access to Neuromuscular Blockade Reversal During Surgery](https://longbridge.com/en/news/294963849.md)
- [Morgan State University Ranked Among Newsweek’s America’s Best Colleges for Women 2026](https://longbridge.com/en/news/295419841.md)
- [MOL: Record Q2 EBITDA driven by high prices, but incidents and price controls constrained some segments](https://longbridge.com/en/news/295225267.md)